153 related articles for article (PubMed ID: 31774822)
1. Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
Abraham M; Kordatou Z; Barriuso J; Lamarca A; Weaver JMJ; Cipriano C; Papaxoinis G; Backen A; Mansoor W
PLoS One; 2019; 14(11):e0224540. PubMed ID: 31774822
[TBL] [Abstract][Full Text] [Related]
2. The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.
Blauwhoff-Buskermolen S; Ruijgrok C; Ostelo RW; de Vet HCW; Verheul HMW; de van der Schueren MAE; Langius JAE
Support Care Cancer; 2016 Feb; 24(2):661-666. PubMed ID: 26160463
[TBL] [Abstract][Full Text] [Related]
3. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
[TBL] [Abstract][Full Text] [Related]
5. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.
Zhou T; Yang K; Thapa S; Fu Q; Jiang Y; Yu S
Support Care Cancer; 2017 Apr; 25(4):1183-1189. PubMed ID: 27900546
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated anorexia: Validity and performance overtime of different appetite tools among patients at their first cancer diagnosis.
Molfino A; de van der Schueren MAE; Sánchez-Lara K; Milke P; Amabile MI; Imbimbo G; Di Lazzaro L; Cavuto S; Ronzani G; Snegovoy A; Gioulbasanis I; Laviano A
Clin Nutr; 2021 Jun; 40(6):4037-4042. PubMed ID: 33676774
[TBL] [Abstract][Full Text] [Related]
9. Association of systemic inflammation and body mass index with survival in patients with resectable gastric or gastroesophageal junction adenocarcinomas.
Gao X; Pan Y; Han W; Hu C; Wang C; Chen L; Guo Y; Shi Y; Pan Y; Xie H; Yao L; Yang J; Zheng J; Li X; Liu X; Hong L; Li J; Li M; Ji G; Li Z; Xia J; Zhao Q; Fan D; Wu K; Nie Y
Cancer Biol Med; 2021 Feb; 18(1):283-297. PubMed ID: 33628601
[TBL] [Abstract][Full Text] [Related]
10. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.
Chau I; Norman AR; Cunningham D; Oates J; Hawkins R; Iveson T; Nicolson M; Harper P; Seymour M; Hickish T
Ann Oncol; 2009 May; 20(5):885-91. PubMed ID: 19164454
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in clinicopathology of oesophagogastric adenocarcinoma: a single-centre longitudinal study of 347 cases over a 20-year period.
Huang Q; Lew E; Cheng Y; Huang K; Deshpande V; Shinagare S; Yuan X; Gold JS; Wiener D; Weber HC
Pathology; 2024 Jun; 56(4):484-492. PubMed ID: 38480051
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of
Knief J; Reddemann K; Lazar-Karsten P; Herhahn T; Petrova E; Wellner U; Thorns C
J Clin Pathol; 2017 Mar; 70(3):274-276. PubMed ID: 28011578
[No Abstract] [Full Text] [Related]
13. Comparison of the performance of four different tools in diagnosing disease-associated anorexia and their relationship with nutritional, functional and clinical outcome measures in hospitalized patients.
Arezzo di Trifiletti A; Misino P; Giannantoni P; Giannantoni B; Cascino A; Fazi L; Rossi Fanelli F; Laviano A
Clin Nutr; 2013 Aug; 32(4):527-32. PubMed ID: 23218121
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.
Arrieta O; Luvián-Morales J; Turcott JG; Oñate-Ocaña LF
Qual Life Res; 2018 Oct; 27(10):2709-2718. PubMed ID: 29987501
[TBL] [Abstract][Full Text] [Related]
15. Validation of the functional assessment of anorexia/cachexia therapy instrument to assess quality of life in maintenance hemodialysis patients with cachexia.
Yang Z; Luo Y; Lu H; Zou B; Wang H; Chen G; Wu Y; Huang Y
Semin Dial; 2022 Jul; 35(4):330-336. PubMed ID: 35032061
[TBL] [Abstract][Full Text] [Related]
16. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Wilke H; Muro K; Van Cutsem E; Oh SC; Bodoky G; Shimada Y; Hironaka S; Sugimoto N; Lipatov O; Kim TY; Cunningham D; Rougier P; Komatsu Y; Ajani J; Emig M; Carlesi R; Ferry D; Chandrawansa K; Schwartz JD; Ohtsu A;
Lancet Oncol; 2014 Oct; 15(11):1224-35. PubMed ID: 25240821
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
[TBL] [Abstract][Full Text] [Related]
18. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma.
Jomrich G; Hollenstein M; John M; Ristl R; Paireder M; Kristo I; Asari R; Schoppmann SF
Ann Surg Oncol; 2019 Apr; 26(4):976-985. PubMed ID: 30706229
[TBL] [Abstract][Full Text] [Related]
19. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
[TBL] [Abstract][Full Text] [Related]
20. FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients.
Turcott JG; Oñate-Ocaña LF; Soca-Chafre G; Ramírez-Tirado LA; Flores-Estrada D; Zatarain-Barrón ZL; Arrieta O
Nutr Cancer; 2019; 71(3):409-417. PubMed ID: 30273069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
